Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Survey finds variation in inherited retinal disease care among U.S. retina specialists
  • Inherited Retinal Disease

Survey finds variation in inherited retinal disease care among U.S. retina specialists

Ophthalmology 360

Key Takeaways

  1. More than 90% of surveyed retina specialists reported actively managing patients with inherited retinal diseases.
  2. Genetic testing was widely used, but only 55% of respondents provided pretest genetic counseling.
  3. Just over half of specialists reported confidence in interpreting genetic test results, highlighting variability in IRD care practices.

Recent advances in genetic testing and emerging therapies for inherited retinal diseases (IRDs) are reshaping clinical care, but a new survey suggests that many U.S. retina specialists vary in how they approach genetic counseling and testing and may have limited confidence in their ability to interpret results.

Of the 481 surveys distributed, 116 were completed. Among those respondents, 101 (87.1%) reported actively managing patients with inherited retinal diseases and were therefore eligible to complete the full survey.

Most respondents were between 40 and 60 years of age, with 54% employed in non-university settings and 46% in university-affiliated practices. Sixty percent reported a comfort level greater than 3 on a 5-point scale when evaluating patients with IRDs.

Overall, 92% of providers reported that they regularly order genetic tests. Only 55% of respondents reported providing genetic counseling before testing, whereas 92% said they counsel patients after receiving test results. Access to an in-house genetic counselor was reported by 40% of participants.

Among physicians who manage IRD patients, 51% reported confidence levels greater than 3 on a 5-point scale for interpreting genetic findings.

The authors concluded that although more than 90% of surveyed retina specialists participate in IRD management, substantial variation in practice patterns and limited confidence in genetic result interpretation underscore the need for clearer guidelines for IRD care.

Reference

Lee P, Nichols B, Wong CW, et al. Inherited Retinal Disease Management in the United States: A Survey of Clinician Practice Patterns. Retina. 2026;doi: 10.1097/IAE.0000000000004910. Epub ahead of print. PMID: 42319905.

Share

Related Content

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Inherited Retinal Disease

Emerging imaging technologies offer hope for inherited retinal disease management

  • Inherited Retinal Disease

Emerging therapies and treatment for rare retinal diseases: a look at the pipeline

  • Inherited Retinal Disease

Breakthroughs in Gene Therapy and Diagnostics: Advancing Treatments and Understanding

  • Inherited Retinal Disease

Limited myopia progression in CSNB patients may guide treatment approaches

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon